It is worth noting that for currently licensed GLP-1 receptor agonists in the UK, the thyroid tumour signal is classified as a precautionary consideration based on rodent data, rather than a formal contraindication as reflected in UK Summaries of Product Characteristics (SmPCs)
Loss of Appetite Although appetite suppression is desired to promote weight loss, it may result in: Skipping meals unintentionally Low energy levels Nutritional deficiencies, if not monitored properly A proper diet becomes essential during GLP-1 treatment
This weight loss was not statistically different from that observed in non-carriers (19.9% weight reduction)
Disclaimer: This information is intended for general knowledge and informational purposes only and does not constitute medical advice
Three high-quality sessions with full recovery between them will produce better results than five mediocre sessions with accumulated fatigue
A Potential New Approach to Addiction Treatment Millions of Americans already use GLP-1 medications, and that number continues to grow
